Authors: van Oosterhout, YVJM van Emst, JL Bakker, HH Preijers, FWMB Schattenberg, AVMB Ruiter, DJ Evers, S Koopman, JP de Witte, T

Citation: Yvjm. Van Oosterhout et al., Production of anti-CD3 and anti-CD7 ricin A-immunotoxins for a clinical pilot study, INT J PHARM, 221(1-2), 2001, pp. 175-186

Authors: van Oosterhout, YVJM van Emst, L Schattenberg, AVMB Tax, WJM Ruiter, DJ Spits, H Nagengast, FM Masereeuw, R Evers, S de Witte, T Preijers, FWMB

Citation: Yvjm. Van Oosterhout et al., A combination of anti-CD3 and anti-CD7 ricin A-immunotoxins for the in vivo treatment of acute graft versus host disease, BLOOD, 95(12), 2000, pp. 3693-3701

Authors: van Horssen, PJ van Oosterhout, YVJM Evers, S Backus, HHJ van Oijen, MGCT Bongaerts, R de Witte, T Preijers, FWMB

Citation: Pj. Van Horssen et al., Influence of cytotoxicity enhancers in combination with human serum on theactivity of CD22-recombinant ricin A against B cell lines, chronic and acute lymphocytic leukemia cells, LEUKEMIA, 13(2), 1999, pp. 241-249